Competitive ELISA method based on foot-and-mouth disease A type VP1 protein and its monoclonal antibody

A technology of FMDV-A-VP1 and foot-and-mouth disease, which is applied in the field of animal immunology detection, can solve the problems of high detection cost, troublesome detection operation, large error of results, etc., and achieve the effect of good stability, strong specificity and high efficiency

Inactive Publication Date: 2014-02-05
广西壮族自治区动物疫病预防控制中心
View PDF4 Cites 24 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to provide a competitive ELISA method based on the foot-and-mouth disease type A VP1 protein and its monoclonal antibody in view of the shortcomings of the existing detection technology for foot-and-mouth disease type A serum, such as high detection cost, troublesome detection operation, and large error in results. To the preparation of monoclonal antibody to type A foot-and-mouth disease protein VP1, and its application in the detection of pathogens and antibodies and the development of vaccines, etc.; established a monoclonal antibody competition ELISA method to detect type A antibody, and formed a type A foot-and-mouth disease immune monitoring technology platform

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Competitive ELISA method based on foot-and-mouth disease A type VP1 protein and its monoclonal antibody
  • Competitive ELISA method based on foot-and-mouth disease A type VP1 protein and its monoclonal antibody
  • Competitive ELISA method based on foot-and-mouth disease A type VP1 protein and its monoclonal antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Obtaining of embodiment 1 foot-and-mouth disease type A VP1 protein

[0043] (1) Primer design

[0044] According to the gene sequence of foot-and-mouth disease virus type A published in GenBank, design a pair of cloning primers (C1, C2) to amplify the sequence containing FMDV-A-VP1 gene, the size is 886bp; design a pair of primers for prokaryotic expression vector and target gene sequence The complete VP1 gene (639bp) is specifically expressed with primers (E1, E2) and inserted into EcoRI and XholⅠ restriction sites. The primer sequences were sent to Dalian Bao Biological Engineering Co., Ltd. for synthesis.

[0045] Table 1 amplifies the primer nucleotide sequence of FMDV-A-VP1 gene

[0046]

[0047] (2) Gene cloning

[0048] Using the gene DNA of foot-and-mouth disease type A virus as a template, use the first pair of cloning primers C1 and C2 to amplify the sequence (886bp) containing the FMDV-A-VP1 gene, and then use the second pair of expression primers E1 a...

Embodiment 2

[0053] The acquisition of embodiment 2 foot-and-mouth disease type A VP1 protein monoclonal antibody

[0054] Step a) Animal immunization: immunize 7-week-old BALB / c female mice with the foot-and-mouth disease A-type VP1 protein 1 induced by the expression plasmid PET-32a-VP1. 1:12800 in mice.

[0055] Step b) cell fusion: get the splenocytes of the immunized mice obtained in step a), carry out cell fusion with myeloma cell SP2 / 0, and use the foot-and-mouth disease A-type VP1 protein 2 induced by the expression plasmid pGEX-6p-1-VP1 as The antigen was coated, and the fused cells were screened by indirect ELISA to obtain hybridoma cells.

[0056] Step c) A large number of cloning of monoclonal antibodies: inject the hybridoma cells obtained in step b) into the peritoneal cavity of mice, feed the injected mice for 1 week, collect ascites from mice with enlarged abdomen, and purify the ascites to obtain foot-and-mouth disease A Type VP1 protein monoclonal antibody.

[0057] Fo...

Embodiment 3

[0058] The competitive ELISA detection method of embodiment 3 porcine foot-and-mouth disease type A serum

[0059] Take the sera of 6 pigs suspected of being infected with FMD type A, and determine whether the sera are negative or positive. Value, data processing, in the competition ELISA detection method:

[0060] Step 1) Sample dilution: the serum sample was diluted to 4 times the original volume to obtain the serum sample to be tested.

[0061] Step 2) Antigen coating: the coating antigen used was FMD A-type VP1 protein 2 induced by the expression plasmid pGEX-6p-1-VP1, and the coating concentration of the coating antigen was 0.625ug / mL.

[0062] Step 3) Blocking: Block the antigen coated in step 2) with 1% BSA solution blocking solution for 40 minutes to obtain a blocked ELISA plate.

[0063] Step 4) Adding sample and adding monoclonal antibody: add the serum sample to be tested obtained in step 1) to the blocked microtiter plate obtained in step 3) to bind the serum ant...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
absorbanceaaaaaaaaaa
Login to view more

Abstract

The invention relates to a competitive ELISA method based on a foot-and-mouth disease A type VP1 protein and its monoclonal antibody, also relates to a preparation method of the foot-and-mouth disease A type VP1 protein, and a preparation method of the monoclonal antibody of the foot-and-mouth disease A type VP1 protein, and belongs to the technical field of animal immunological detection. In the invention, a primer pair C1 and C2 and a primer pair E1 and E2 are amplified to obtain a gene sequence of the foot-and-mouth disease A type VP1 protein, the foot-and-mouth disease A type VP1 protein is obtained by constructing an expression plasmid, introducing the expression plasmid into a prokaryotic expression host and carrying out inducible purification, the foot-and-mouth disease A type VP1 protein monoclonal antibody is obtained by treating the foot-and-mouth disease A type VP1 protein as an antigen through a hybridomas technology, and the competitive ELISA method used for detecting a foot-and-mouth disease A type antibody is established based on the foot-and-mouth disease A type VP1 protein and its monoclonal antibody. The detection method has a strong specificity and a good stability, and can be used for detecting a foot-and-mouth disease A type serum antibody. By comparing a result obtained through the detection method with a liquid phase blocking ELISA kit, the coincidence rate is 95.8%.

Description

technical field [0001] The invention belongs to the technical field of animal immunology detection, and in particular relates to a foot-and-mouth disease type A VP1 protein and a preparation method thereof, and a competition ELISA method based on the prepared foot-and-mouth disease type A VP1 protein and a monoclonal antibody thereof. Background technique [0002] Foot-and-mouth disease is a highly contagious and economically important animal disease caused by foot-and-mouth disease virus (FMDV), infecting cattle, pigs, sheep, goats and other artiodactyls. After animals are infected with foot-and-mouth disease, blisters will appear in the mouth, hooves, nipples and other parts to form erosions, and the diseased animals are generally benign. Although the death rate of foot-and-mouth disease is low, due to its high incidence rate of almost 100% and its rapid spread, it restricts the development of animal husbandry and the participation of countries in international trade of an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/09C07K16/10C12N15/42C12N15/70G01N33/577
CPCC07K14/005C07K16/1009C07K2319/00C12N15/62C12N15/70C12N2770/32122G01N33/56983G01N33/577G01N2333/09
Inventor 熊毅蒋家霞冯淑萍颜健华
Owner 广西壮族自治区动物疫病预防控制中心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products